Preclinical Pharmacokinetics and Efficacy of Debio 1450 (Previously AFN-1720), a Prodrug of the Staphylococcocal-specific Antibiotic Debio 1452 (Previously AFN-1252)

N. Kaplan (1;3), B. Hafkin (2;3)

Presented at ECCMID 2014, Barcelona, Spain

(1) Affinium Pharmaceuticals, Toronto, ON, Canada

(2) Affinium Pharmaceuticals, Austin, TX, USA

(3) Debiopharm International SA, Lausanne, Switzerland